Bloom Public Health, Suite D6, Mazado Plaza, Mongonu Shettima, Utako, Abuja, Nigeria.
National Institute for Pharmaceutical Research & Development, Abuja, Nigeria.
J Public Health Policy. 2023 Jun;44(2):276-284. doi: 10.1057/s41271-023-00405-w. Epub 2023 Mar 30.
The COVID-19 pandemic unveiled the vulnerability of many African healthcare systems, amplifying inadequacies and constraints in the supply chain for medical products and technologies on the continent. Disruptions in the global supply chain due to the pandemic resulted in the continent's population of over one billion people grappling with shortages in the supply of essential medicines. The shortages and their consequences set back achievement of Sustainable Development Goals and progress towards universal health coverage. A virtual meeting of global experts in medical products and supply chain identified as urgent the need for Africa to build capacity for a self-reliant public health system. Discussants challenged the governments of African countries to turn the continent from its current import driven economy to a continent of indigenous research and development, local production, and an exporter of its medical products and innovations.
新冠疫情揭示了许多非洲医疗体系的脆弱性，凸显了非洲在医疗产品和技术供应链方面的不足和限制。由于疫情导致的全球供应链中断，非洲 10 多亿人口面临基本药物供应短缺的问题。这些短缺及其后果使可持续发展目标的实现和全民健康覆盖的进展受到阻碍。一次关于医疗产品和供应链的全球专家虚拟会议认为，非洲迫切需要建立自力更生的公共卫生系统的能力。与会者向非洲国家政府提出挑战，要求他们将非洲从目前的进口驱动型经济转变为一个本土研究和开发、本地生产以及出口其医疗产品和创新的大陆。
